Drug intelligence / Profile preview

Prevenox

Development stage
Unknown
Lead developer
Centro Nacional de Investigaciones Científicas
Modality
Small Molecules
Administration
Oral
01

Overview

Prevenox is a natural nutritional supplement developed by the Centro Nacional de Investigaciones Científicas (CNIC) in Cuba. Its active ingredient is a purified mixture of high molecular weight aliphatic fatty acids extracted from sugarcane wax (*Saccharum officinarum* L.). Prevenox is primarily indicated for the management of hypercholesterolemia and the prevention and treatment of osteoporosis and osteoarthritis, particularly in middle-aged and elderly populations. The supplement exhibits a multi-faceted pharmacological profile, including antioxidant, lipid-lowering, antiplatelet, and osteoprotective activities. It is commercialized through Laboratorios Dalmer, the commercial entity of CNIC. While its precise molecular targets remain uncharacterized, it is recognized for its ability to modulate lipid profiles and support bone health through natural metabolic pathways.

Brand names
Prevenox
Other names
Sugarcane wax fatty acids

Beyond the preview

Go deeper on Prevenox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prevenox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call